SCHEMBL24289934

SCHEMBL24289934

N/C=C(/c1cnc2ccc(Br)cc2n1)C(N)C1CC1

nearest known ligand 0.35

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
▸ DPP4 P27487 1/20 0.32
▸ PABPC1 P11940 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28750182 0.70 ABL1 (0.44) —
SCHEMBL24289048 0.69 TGFBR1 (0.33) PABPC1
SCHEMBL24292074 0.68 ABL1 (0.33) PABPC1
SCHEMBL13905406 0.67 ALDH1A1 (0.61) —
SCHEMBL1600169 0.66 BACE1 (0.57) PABPC1
SCHEMBL29987438 0.66 BACE1 (0.57) PABPC1
SCHEMBL15447229 0.66 HTT (0.46) —
SCHEMBL2621767 0.66 CSF1R (0.42) PABPC1
SCHEMBL12850736 0.66 ALDH1A1 (0.42) —
SCHEMBL21746904 0.65 HPGD (0.33) DPP4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022073469-A1 COMPOUNDS AND METHODS OF TREATING CANCERS CULLGEN (SHANGHAI) , INC. (CN) 2022-04-14 — — WO disclosed
Send feedback